Email Updates

Search form

You are here

Trial Summary Table

Trial Name Phase Start Date Sponsors Countries Population Candidate(s) Status Expected Completion Date
MTN 004 I Thursday, May 8, 2014 NIAID, US Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, MTN, ATN United States of America, Puerto Rico Women VivaGel™, HEC gel Completed May 2014
MTN 005 II Tuesday, May 31, 2011 Population Council, NIAID, NIMH, MTN India, United States of America Women Completed September 2012
MTN 007 I Sunday, October 31, 2010 CONRAD, NIAID United States of America Women, Men HEC gel, 1% tenofovir gel Completed July 2011
MTN 008 I Thursday, March 31, 2011 NIAID, CONRAD, MTN United States of America Women 1% tenofovir gel Completed September 2013
MTN 011 I Friday, November 30, 2012 CONRAD, MTN, NIAID, NIMH United States of America Women, Men 1% tenofovir gel Completed April 2015
MTN 012/IPM 010 I Thursday, March 31, 2011 International Partnership for Microbicides, Inc, NIAID, MTN United States of America Men HEC gel, dapivirine gel Completed July 2011
MTN 014 I Wednesday, October 31, 2012 CONRAD, MTN, NIAID, NIMH South Africa, United States of America Women 1% tenofovir gel Completed December 2014
MTN 015 Other Sunday, August 31, 2008 MTN, NIAID South Africa, Uganda, Malawi, Zimbabwe HIV positive Ongoing November 2020
MTN 016 (EMBRACE) Open Label Saturday, October 31, 2009 MTN, NIAID, CONRAD, NICHD United States of America, Zimbabwe, South Africa, Malawi, Uganda Women Ongoing November 2020
MTN 017 II Monday, September 30, 2013 CONRAD, MTN, NIAID, NIMH Thailand, South Africa, United States of America, Puerto Rico, Peru Transgender, MSM Reduced Glycerin 1% Tenofovir Gel, TDF/FTC (Truvada) Completed May 2015

Pages